Ethical considerations
This protocol is extracted from research article:
“I’ll tell you what’s important to me…”: lessons for women’s health screening
BMC Womens Health, Feb 18, 2021; DOI: 10.1186/s12905-021-01220-9

The study protocol was reviewed and determined not human subjects research by the relevant Institutional Review Board that reviews all studies for the medical education center that hosted this project. The author is not allowed to name the specific institutional review board/ethics committee that made this determination as it was, at the time of the study, the only such ethics committee that reviewed all studies for any research conducted at the study site: it is based at a hospital where all study participants either provide or receive care and connected to the network of family medicine clinics for which the screening tools were developed, thus naming the ethics committee would risk identifying the site and participants. Under the study protocol and consent process reviewed by the ethics committee, both the site and the participants must be kept de-identified. Naming the specific ethics review committee would violate the approved study protocol. All participants gave verbal informed consent. There were no incentives for participation in the study. The study did not gather participant-identifying information aside from connection to and role with the study site.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.